Madrigal pharmaceuticals appoints carole huntsman as chief commercial officer

Conshohocken, pa., nov. 10, 2023 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (nash), today announced that carole huntsman has been appointed chief commercial officer.

MDGL Ratings Summary

MDGL Quant Ranking